GPC1 and pancreatic ductal adenocarcinoma: Melo et al. studied GPC1 expression in the peripheral blood of 190 patients with pancreatic ductal adenocarcinoma and 100 healthy volunteers and found that GPC1 was highly expressed in patients with cancer compared with the healthy volunteers; furthermore, larger tumors showed a higher positive rate of GPC1.